期刊文献+

冠脉内支架植入术后再狭窄的危险因素分析 被引量:2

Analysis of risk factors of restenosis after coronary stenting
暂未订购
导出
摘要 目的 分析冠脉内支架植入术后再狭窄的危险因素。方法 自 1996年 1月至 2 0 0 0年 9月 10 2 5例冠脉内支架植入术患者中 ,10 1例因胸痛复发或由于医生动员而行冠脉造影随访 ,记录这些患者的冠心病易患因素 ,对病变狭窄程度及长度用QCA测定 ,以支架植入节段内径≥ 5 0 %为再狭窄。结果  10 1例患者共 12 2处病变植入支架 ,造影显示支架内再狭窄 5 2例 (6 2处病变 )。多因素逐步回归分析显示 ,再狭窄与血浆胆固醇 ,Lp(a) ,尿酸浓度、术前狭窄程度、术后残余狭窄呈正相关 ,其比数比(OR)分别为 1.2 1、1.94、1.13、1.0 7和 1.6 3;与术前参考血管直径和支架呈显著负相关 ,OR分别为 0 .2 4和 0 .31。结论 冠脉内支架植入术后再狭窄受多因素的影响 ,控制血脂 ,避免冠脉内小支架应用以及术后即刻疗效满意对减低冠脉内支架植入术后再狭窄具有重要作用。 Objective To analyse the risk factors of restenosis after coronary stenting.Methods In 1 025 cases who underwent coronary stenting between January 1996 and September 2000, follow up coronary angiography was performed in 101 patients due to chest pain or doctor's advise. Risk factors for coronary artery disease were recorded. The degree of stenosis and length of lesions were measured by QCA. Results In 101 patients, coronary stents were implanted for 122 lesions. In stent restenosis (luminal narrowing ≥50%) occurred in 62 lesions of the 52 patients. Logistic regression analysis revealed stent restenosis correlated positively correlated closely with plasma levels of cholesterol (OR 1.21), Lp(a) (OR 1.94),uric acid(OR 1.13) and degree of coronary stenosis before the procedure (OR 1.07) and residual stenosis after stenting (OR 1.63). It was inversely proportional to the diameter of reference vessel (OR 0.24) and stents (OR 0.31). Conclusions The occurrence of restenosis after coronary stenting may be influenced by multiple factors. Controlling plasma lipid profile, avoiding small coronary stents and obtaining better results immediately after procedure are crucial for the reduction of overall restenosis rate.
出处 《介入放射学杂志》 CSCD 2001年第2期75-77,共3页 Journal of Interventional Radiology
关键词 支架植入术 再狭窄 危险因素 冠心病 治疗 Coronary stenting Restenosis Risk factor
  • 相关文献

参考文献1

二级参考文献1

  • 1郭静萱,中华心血管病杂志,1996年,24卷,1页

共引文献32

同被引文献27

  • 1郗永安,汪丽蕙,朱国英,张钧华.局部应用反义核酸对大鼠颈动脉肌内膜增殖的抑制作用[J].中华医学杂志,1996,76(2):109-111. 被引量:3
  • 2Nishimoto Y,Mlyazaki Y,Toki Y, et al. Enhanced secretion of insulin pays a role in the development of atherosclerosis and restenosis of coronary arteies: Elective percutaneous transluminal coronary angioplasty in patients with effort andgina[J]. J Am Coll
  • 3Lau K W, Ding Z P, Johan A, et al. Midterm angiographic outcome of single - vessel intracoronary stent placement in diabetic versus nondiabetic patients: A matched comparative study[J ]. Am Heart J, 1998,136( 1 ): 150 - 155.
  • 4Gazzaruso C,Garzaniti A,Falcone C, et al. Lioprotein(a),apolipoprotein(A) polymorphism and restenosis after intracoronary stent placement in type 2 diabetic patients[J ]. J Diabetes Complications, 2003,17 (3): 135 - 140.
  • 5Carlsson R. Serum cholesterol, lifestyle, working capacit and quality of life in patients with coronary artery disease: Experiences from a hospital - based secondary prevention programme[ J ]. Scand Cardiovasc J, 1998,50:1 - 20.
  • 6Gustavsson C G, Persson S, Thorvinger B O, et al. Association between pre- PTCA blood haemoglobin concentration and the risk of symptomatic restenosis after successful PTCA of primary coronary stenosis [ J ]. J Cardiovasc Risk,1997,4( 1 ) :37 - 40.
  • 7Jimi S, Saku K, Kusaba H, et al. Deposition of oxidized lowdensit lipoprotein and collagenosis occur coincidentally in human coronary stenosis: An immunobistochemical study of atherectomy[J ]. Coron Artery Dis, 1998,9(9) :551 - 557.
  • 8Ludia C, Domenico P, Monia C, et al. Antiphospholipid antibodies: A new risk factor for restenosis after percutaneous transluminal coronary angioplasty? [ J ]. Autoimmunity.1998,27(3): 141 - 148.
  • 9Mckenna K T, Maas F, McEniery PT, et al. Coronary risk factor status after percutaneous transluminal coronary angioplasty[ J ]. Heart Lung, 1995,24 (3): 207 - 212.
  • 10Terres W. Staged diagnosis in suspected restenosis after PTCA- introduction[J]. Z Kardiol, 1998,87(2) :214.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部